KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Revenue (2016 - 2025)

Astrana Health (ASTH) has disclosed Revenue for 16 consecutive years, with $950.5 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 42.89% to $950.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 billion through Dec 2025, up 56.39% year-over-year, with the annual reading at $3.2 billion for FY2025, 56.39% up from the prior year.
  • Revenue hit $950.5 million in Q4 2025 for Astrana Health, down from $956.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $956.0 million in Q3 2025 to a low of $175.6 million in Q2 2021.
  • Historically, Revenue has averaged $426.1 million across 5 years, with a median of $348.2 million in 2023.
  • Biggest five-year swings in Revenue: increased 6.34% in 2021 and later skyrocketed 99.71% in 2025.
  • Year by year, Revenue stood at $195.1 million in 2021, then surged by 50.8% to $294.2 million in 2022, then increased by 20.0% to $353.0 million in 2023, then skyrocketed by 88.43% to $665.2 million in 2024, then surged by 42.89% to $950.5 million in 2025.
  • Business Quant data shows Revenue for ASTH at $950.5 million in Q4 2025, $956.0 million in Q3 2025, and $654.8 million in Q2 2025.